Edition:
United States

People: Nike Inc (NKE.N)

NKE.N on New York Stock Exchange

53.19USD
21 Sep 2017
Change (% chg)

$-0.37 (-0.69%)
Prev Close
$53.56
Open
$53.55
Day's High
$53.63
Day's Low
$53.09
Volume
1,697,841
Avg. Vol
2,489,098
52-wk High
$60.53
52-wk Low
$49.04

Lechleiter, John 

Dr. John C. Lechleiter, Ph.D. is an Independent Director of Nike, Inc. He is the former Chairman of the Board, President, and Chief Executive Officer of Eli Lilly and Company (“Lilly”). He served as President and Chief Executive Officer from April 1, 2008 until December 2016. He served as a member of Lilly’s board of directors from 2005 to May 2017 and as Chairman of Lilly’s board from January 2009 to May 2017. Dr. Lechleiter began work at Lilly as a senior organic chemist in Lilly’s process research and development division in 1979 and became head of that department in 1982. He later held roles in project management, regulatory affairs, product development, and pharmaceutical operations. He was named President and Chief Operating Officer in 2005. He is a member of the American Chemical Society. He served on the board of Pharmaceutical Research and Manufacturers of America from February 2008 until December 2016. He also served as Chairman of the U.S.-Japan Business Council until November 2016. He serves on the board of United Way Worldwide, and on the boards of the Chemical Heritage Foundation and Ford Motor Company. He is a member emeritus of the board of the Central Indiana Corporate Partnership.

Basic Compensation

Total Annual Compensation, USD 105,000
Restricted Stock Awards, USD 165,011
Long-Term Incentive Plans, USD --
All Other, USD 21,961
Fiscal Year Total, USD 291,972

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Mark Parker

13,851,500

Andrew Campion

3,946,260

Trevor Edwards

4,986,330

Michael Spillane

3,511,230

Eric Sprunk

4,444,100

Hilary Krane

--
As Of  30 May 2017